Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0700
-0.0058 (-7.65%)
Nov 6, 2026, 2:58 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 85.93 million as of November 6, 2026. It is the 39,233rd most valuable company in the world and the 109th biggest in Denmark. Its market cap has decreased by 27.69% in one year.
Market Cap
85.93M
Enterprise Value
96.64M
Revenue
n/a
Global Rank
Country Rank
#109 Denmark
PE Ratio
n/a
ChartMarket Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 85.93M, a decrease of -88.80%. That is a compound annual growth rate of -45.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 85.93M | -25.05% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.26T |
| Genmab | 213.80B |
| Coloplast | 117.72B |
| Demant | 79.17B |
| Gubra | 4.84B |
| BioPorto | 502.54M |
| Scandinavian Medical Solutions | 72.85M |
| ViroGates | 71.01M |